Home LiteratureArticle Details
PMID: 15699325 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Phosphorylation at Thr-290 regulates Tpl2 binding to NF-kappaB1/p105 and Tpl2 activation and degradation by lipopolysaccharide.

Cho J, Tsichlis PN

Abstract

The serine-threonine protein kinase encoded by the Tpl2 protooncogene transduces Toll-like and death receptor signals in a variety of cell types and plays an important role in innate immunity and inflammation. Differential translational initiation of the Tpl2 mRNA gives rise to 58-kDa (p58) and 52-kDa (p52) isoforms. In unstimulated cells, both isoforms are stabilized and inactivated by stoichiometric binding to NF-kappaB1/p105. After lipopolysaccharide or TNF-alpha stimulation, p58 is released from p105 preferentially relative to p52. The released p58 is active but unstable and undergoes rapid degradation via the proteasome. Recent studies revealed that Tpl2 undergoes phosphorylation at Thr-290 and that phosphorylation at this site is required for activation. Here, we present evidence showing that it is the p58 isoform that is preferentially phosphorylated at Thr-290 and that phosphorylation is more efficient when p58 is complexed to p52. Because p58 is preferentially released from p105 after stimulation, we examined whether Tpl2 phosphorylation at this site controls the dissociation of the two proteins in response to external signals and the subsequent events leading to the activation of Tpl2. The results showed that lipopolysaccharide-induced Tpl2 phosphorylation at Thr-290 in macrophages promotes the release of Tpl2 from p105, contributes to the enzymatic activation of the Tpl2 kinase, and is required for the degradation of Tpl2 via the proteasome.

MeSH Terms
Animals Binding Sites/genetics Cell Line Lipopolysaccharides/pharmacology MAP Kinase Kinase Kinases/chemistry,genetics,metabolism Macrophages/drug effects,metabolism Mice Models, Biological Multiprotein Complexes Mutagenesis, Site-Directed NF-kappa B p50 Subunit Phosphorylation Protease Inhibitors/pharmacology Protein Isoforms/chemistry,genetics,metabolism Proto-Oncogene Proteins/chemistry,genetics,metabolism RNA, Messenger/genetics Recombinant Proteins/chemistry,genetics,metabolism Threonine/chemistry Transcription Factors/metabolism
Chemicals
Lipopolysaccharides Multiprotein Complexes NF-kappa B p50 Subunit Protease Inhibitors Protein Isoforms Proto-Oncogene Proteins RNA, Messenger Recombinant Proteins Transcription Factors Nfkb1 protein, mouse Threonine MAP Kinase Kinase Kinases Map3k8 protein, mouse
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Cho Jeonghee
Molecular Oncology Research Institute, Tufts-New England Medical Center and Tufts Cancer Center, Boston, MA 02111, USA.
Tsichlis Philip N
References (23)
23 references, click to expand
  1. The human cot proto-oncogene encodes two protein serine/threonine kinases with different transforming activities by alternative initiation of translation.
    J Biol Chem. 1993 Oct 25;268(30):22723-32 PMID: 8226782
  2. Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the progression of rodent T-cell lymphomas and in T-cell activation.
    Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2251-5 PMID: 7681591
  3. Proteolytic processing of NF-kappa B/I kappa B in human monocytes. ATP-dependent induction by pro-inflammatory mediators.
    J Biol Chem. 1995 Jan 6;270(1):9-12 PMID: 7814425
  4. Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase.
    EMBO J. 1996 Feb 15;15(4):817-26 PMID: 8631303
  5. Involvement of the Tpl-2/cot oncogene in MMTV tumorigenesis.
    Oncogene. 1996 Nov 7;13(9):2015-20 PMID: 8934549
  6. Tpl-2 is an oncogenic kinase that is activated by carboxy-terminal truncation.
    Genes Dev. 1997 Mar 15;11(6):688-700 PMID: 9087424
  7. The Tpl-2 protooncoprotein activates the nuclear factor of activated T cells and induces interleukin 2 expression in T cell lines.
    Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3827-32 PMID: 9520452
  8. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.
    Oncogene. 1998 Nov 19;17(20):2609-18 PMID: 9840924
  9. TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105.
    Nature. 1999 Jan 28;397(6717):363-8 PMID: 9950430
  10. The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-kappaB acting through the NF-kappaB-inducing kinase and IkappaB kinases.
    Immunity. 1999 Feb;10(2):271-80 PMID: 10072079
  11. Phosphorylation of threonine 290 in the activation loop of Tpl2/Cot is necessary but not sufficient for kinase activity.
    J Biol Chem. 2004 Dec 10;279(50):52117-23 PMID: 15466476
  12. Multiple mitogen-activated protein kinase signaling pathways connect the cot oncoprotein to the c-jun promoter and to cellular transformation.
    Mol Cell Biol. 2000 Mar;20(5):1747-58 PMID: 10669751
  13. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway.
    Cell. 2000 Dec 22;103(7):1071-83 PMID: 11163183
  14. p27kip protein levels and E2F activity are targets of Cot kinase during G1 phase progression in T cells.
    J Immunol. 2001 May 15;166(10):6084-90 PMID: 11342626
  15. Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals.
    EMBO J. 2002 Sep 16;21(18):4831-40 PMID: 12234923
  16. Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease.
    J Exp Med. 2002 Dec 16;196(12):1563-74 PMID: 12486099
  17. NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase.
    Mol Cell. 2003 Mar;11(3):685-94 PMID: 12667451
  18. NF-kappaB1 p105 negatively regulates TPL-2 MEK kinase activity.
    Mol Cell Biol. 2003 Jul;23(14):4739-52 PMID: 12832462
  19. Tpl2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40.
    EMBO J. 2003 Aug 1;22(15):3855-64 PMID: 12881420
  20. The COOH-terminal domain of wild-type Cot regulates its stability and kinase specific activity.
    Mol Cell Biol. 2003 Oct;23(20):7377-90 PMID: 14517305
  21. IkappaB kinase is an essential component of the Tpl2 signaling pathway.
    Mol Cell Biol. 2004 Jul;24(13):6040-8 PMID: 15199157
  22. Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IkappaB kinase-induced proteolysis of NF-kappaB1 p105.
    Mol Cell Biol. 2004 Nov;24(21):9658-67 PMID: 15485931
  23. Tpl-2 acts in concert with Ras and Raf-1 to activate mitogen-activated protein kinase.
    Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9755-9 PMID: 7937886
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2005-02-15
Epub
2005-00-07
Pages
2350-5
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC548980
Subset
IM
Grants
NCI NIH HHS · CA R01 38047 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com